Relay Therapeutics
Designs small-molecule medicines around protein motion for cancer and genetic disease.
$19.10
After-hours close+0.34 (+1.82%)
At close$18.76(−3.40%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 114.66%Insiders 0.87%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 219.14M · Float 171.50M · 78.3% free float
Institutions13F, as of Jun 30, 2026
268 holders · 251.27M shares · 54 new positions · 170 increased · 63 reduced · 36 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| SB Investment Advisers (UK) Ltd | 27.90M | 12.73% | 0 | Aug 14, 2026 |
| FMR LLC | 20.11M | 9.18% | +16.41M | Aug 13, 2026 |
| Casdin Capital, LLC | 16.04M | 7.32% | +1.62M | Aug 14, 2026 |
| BlackRock, Inc. | 15.29M | 6.98% | +2.31M | Aug 7, 2026 |
| Perceptive Advisors LLC | 14.11M | 6.44% | +4.36M | Aug 14, 2026 |
| Commodore Capital LP | 12.00M | 5.48% | −5.00M | Aug 14, 2026 |
| State Street Corp | 10.13M | 4.62% | +3.89M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 8.96M | 4.09% | +1.58M | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Perceptive Advisors LLC | 9.99% | 13G | Apr 13, 2026 ↗ | |
| Commodore Capital LP | 9.90% | 17.00M | 13G | Nov 14, 2025 ↗ |
| Casdin Capital, LLC | 7.50% | 13.00M | 13G | Feb 17, 2026 ↗ |
| BlackRock, Inc. | 6.10% | 10.31M | 13G | Apr 17, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| SVF Pauling (Cayman) Ltd | 10 percent owner | 21.90M | 10.00% | Aug 28, 2026 |
| Sanjiv Patel | director, officer: President and CEO | 767.2K | 0.35% | Aug 18, 2026 |
| Donald A. Bergstrom | officer: President, R&D | 407.7K | 0.19% | Jul 30, 2026 |
| Brian Adams | officer: Chief Legal Officer | 371.5K | 0.17% | Jul 30, 2025 |
| Peter Rahmer | officer: See remarks | 223.7K | 0.10% | Aug 28, 2026 |
| Thomas Catinazzo | officer: Chief Financial Officer | 140.6K | 0.06% | Aug 18, 2026 |
3 ten-percent owners hold 26.15M shares by Form 4, outside the officers-and-directors figure above · 6 people have not refiled in the last 18 months (1.41M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 26, 2026 | Peter Rahmerofficer: See remarks | Sale | 4,508 | $20.03 | 223,657 |
| Aug 25, 2026 | SVF Pauling (Cayman) Ltd10 percent owner | Sale | 6,000,000 | $19.40 | 21,904,963 |
| Aug 14, 2026 | Thomas Catinazzoofficer: Chief Financial Officer | Sale | 17,717 | $19.74 | 140,568 |
| Aug 17, 2026 | Sanjiv Pateldirector, officer: President and CEO | Sale | 48,199 | $20.33 | 567,699 |
| Jul 28, 2026 | Donald A. Bergstromofficer: President, R&D | Sale | 2,237 | $18.61 | 407,660 |
| Jul 28, 2026 | Peter Rahmerofficer: See remarks | Sale | 748 | $18.61 | 228,165 |
| Jul 28, 2026 | Thomas Catinazzoofficer: Chief Financial Officer | Sale | 1,459 | $18.61 | 158,285 |
| Jul 6, 2026 | Thomas Catinazzoofficer: Chief Financial Officer | Sale | 17,717 | $18.69 | 159,744 |
| Jul 7, 2026 | Sanjiv Pateldirector, officer: President and CEO | Sale | 48,199 | $19.58 | 615,898 |
| Jul 6, 2026 | Donald A. Bergstromofficer: President, R&D | Sale | 8,660 | $18.71 | 409,897 |
CongressHouse and Senate disclosures
Not reported.